Nov
01

CBER official sees need in Phase II, but new EU Annex 13 may differ. : An article from: Validation Times

By Pharma Tech


Product Description
This digital document is an article from Validation Times, published by Washington Information Source on September 1, 2002. The length of the article is 800 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: CBER official sees need in Phase II, but new EU Annex 13 may differ. (Cleaning validation).(Center for Biologics Evaluation and Research)(European Union)
Author: Ken Reid
Publication: Validation Times (Newsletter)
Date: September 1, 2002
Publisher: Washington Information Source
Volume: 4 Issue: 9 Page: 2

Distributed by Thomson Gale
CBER official sees need in Phase II, but new EU Annex 13 may differ. : An article from: Validation Times

Share and Enjoy:
  • Print this article!
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks
Categories : Trials

Leave a Comment

CommentLuv Enabled

This site uses KeywordLuv. Enter YourName@YourKeywords in the Name field to take advantage.